Protara Therapeutics (TARA) Change in Acquisitions & Divestments (2014 - 2026)

Protara Therapeutics (TARA) has 11 years of Change in Acquisitions & Divestments data on file, last reported at $29.1 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 288.48% year-over-year to $29.1 million in Q1 2026; TTM through Mar 2026 was $86.9 million, a 163.24% increase from a year earlier, with the FY2025 full-year figure at $65.2 million, up 34.23% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $29.1 million, down from $35.8 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for TARA reached as high as $35.8 million in Q4 2025 and fell as low as $3.0 million in Q2 2024.
• Historically, Change in Acquisitions & Divestments has averaged $17.0 million across 5 years, with a median of $18.5 million in 2022.
• Across the five-year window, Change in Acquisitions & Divestments tumbled 86.58% in 2024 and soared 288.48% in 2026, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $10.8 million in 2022, then soared by 34.64% to $14.5 million in 2023, then soared by 54.98% to $22.5 million in 2024, then jumped by 59.22% to $35.8 million in 2025, then dropped by 18.67% to $29.1 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $29.1 million in Q1 2026, $35.8 million in Q4 2025, and $17.9 million in Q3 2025.